Chronic Lymphocytic Leucemia Recruiting Phase 2 Trials for Bendamustine (DB06769)

IndicationStatusPhase
DBCOND0074005 (Chronic Lymphocytic Leucemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs